why choose us

First received: February 14, 2023

Clinical Trial: Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension

Study Status: Completed

Recruit Status: RECRUITING

Condition: Depressive Disorder

Study Type: INTERVENTIONAL


Official Title: Open Label Extension Study of Depressed Mood Improvement Through Nicotine (Depressed MIND3)

Brief Summary: Deficits in cognitive control are core features of late-life depression (LLD), contributing both to emotion dysregulation and problems with inhibiting irrelevant information, conflict detection, and working memory.Clinically characterized as executive dysfunction, these deficits are associated with poor response to antidepressants and higher levels of disability.Improvement of cognitive control network (CCN) dysfunction may benefit both mood and cognitive performance, however no current pharmacotherapy improves…

Read more